期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
TACE联合高频热疗、中药肝癌汤治疗原发性肝癌疗效观察 被引量:1
1
作者 范孝成 李营 《亚太传统医药》 2014年第15期46-47,共2页
目的:探讨TACE联合高频热疗、中药肝癌汤内服治疗原发性肝癌的临床疗效。方法:选择原发性肝癌病人30例,随机分为治疗组与对照组各15例。治疗组在TACE治疗时联合局部高频热疗和内服中药肝癌汤;对照组采用TACE治疗,比较两组患者的临床疗... 目的:探讨TACE联合高频热疗、中药肝癌汤内服治疗原发性肝癌的临床疗效。方法:选择原发性肝癌病人30例,随机分为治疗组与对照组各15例。治疗组在TACE治疗时联合局部高频热疗和内服中药肝癌汤;对照组采用TACE治疗,比较两组患者的临床疗效、疾病相关症状改善及不良反应。结果:治疗组临床疗效及疾病相关症状改善明显优于对照组,不良反应发生率低于对照组。结论:经TACE联合局部高频热疗和中药肝癌汤内服是治疗原发性肝癌的有效方法,值得临床推广应用。 展开更多
关键词 肝癌 高频热疗 中药 肝癌汤 疗效观察
下载PDF
自拟肝癌汤改善晚期肝癌患者生存质量32例 被引量:2
2
作者 柳玉美 《光明中医》 2011年第9期1822-1823,共2页
目的改善晚期肝癌患者生存质量。方法运用自拟肝癌汤治疗晚期肝癌32例,与单用保肝对症治疗的晚期肝癌30例做比较观察。结果两组生活质量与生存率有显著差异(P<0.05)。结论证明自拟肝癌汤应用于晚期肝癌,能有效地控制病情及延缓病情发... 目的改善晚期肝癌患者生存质量。方法运用自拟肝癌汤治疗晚期肝癌32例,与单用保肝对症治疗的晚期肝癌30例做比较观察。结果两组生活质量与生存率有显著差异(P<0.05)。结论证明自拟肝癌汤应用于晚期肝癌,能有效地控制病情及延缓病情发展,提高生活质量,延长生存时间。 展开更多
关键词 自拟肝癌汤肝癌 生活质量
下载PDF
Antitumor and synergistic effect of Chinese medicine “Bushen huayu jiedu recipe” and chemotherapy on transplanted animal hepatocarcinoma 被引量:7
3
作者 Yong Cao Qing-Hua Xia +1 位作者 Hua Meng An-Pu Zhong 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第33期5218-5220,共3页
AIM: To investigate the antitumor and synergistic effect of Chinese medicine “Bushen huayu jiedu recipe” (recipe for invigorating the kidney, removing blood stasis and toxic substances) and chemotherapy on mice h... AIM: To investigate the antitumor and synergistic effect of Chinese medicine “Bushen huayu jiedu recipe” (recipe for invigorating the kidney, removing blood stasis and toxic substances) and chemotherapy on mice hepatocarcinoma. METHODS: Bushen huayu jiedu recipe (BSHYJDR) consisting of Chinese Cassia Bark, Psoralea, Zedoary, Rhubarb, etc. is equal to 1.5 g/mL liquid of originated herbs after being decoded, filtered, and concentrated. Kunming mice, weighing 18-22 g, were injected with 0.2 mL ascitic hepatocarcinoma H22 containing 1 × 10^7 cells/mL into armpit of the right forelimb of mice. After 24 h, the mice were weighed and randomly divided into tumor-bearing model control group, cisplatin (DDP) group, BSHYJDR high dosage group, low dosage BSHYJDR group, DDP combined with high and low dosage BSHYJDR group, 10 mice in each group. DDP group received injection intraperitoneally (ip) at the dosage of 1 mg/kg (equal to 1/10 LD50), once a day for 4 d. High and low dosage BSHYJDR groups received intragastric BSHYJDR at the dosages of 26.6 and 13.3 g/kg (20 and 10 times each of clinical adult dosage) respectively, while tumor-bearing model group received the equal volume of distilled water once a day for 10 d. On the 11^th d, the mice were weighed and killed, then the tumor was dissected and weighed, the repression rate (RR) was calculated according to the mean weight of tumor (MWT). RESULTS: Compared to the model group (MWT: 1.30±0.73), DDP group (MWT: 0.41±0.09, RR: 68.46%) had a significant difference in the inhibition of hepatocarcinoma H22 (P〈0.01). High dosage BSHYJDR group (MWT: 0.69±0.29, RR: 46.92%) also had a significant difference in inhibition (P〈0.05), while no difference was found in low dosage BSHYJDR group (MVVT: 0.85±0.34, RR: 34.62%) (P〉0.05). When DDP was combined with high dosage BSHYJDR (MWT: 0.29±0.17, RR: 77.69%) and low dosage BSHYJDR (MWT: 0.38±0.21, RR: 70.77%) respectively, we could see improvement of the inhibition effect of DDP on transplanted hepatocarcinoma H22. DDP combined with high dosage BSHYJDR had a significant difference (P〈0.001) compared to DDP, while DDP combined with low dosage BSHYJDR only had a little improvement that is not remarkable. CONCLUSION: Chinese medicine BSHYJDR in combination with chemotherapy can inhibit transplanted hepatocarcinorna in mice. 展开更多
关键词 Bushen huayu jiedu recipe Mice hepatocarcinoma H22 Antitumor effects Synergy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部